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Background
Cholesterol plays essential roles in the physiology of the
central nervous system, ranging from axonal transport
to synaptic plasticity [1,2]. Cholesterol metabolism
maintenance is guaranteed by an intricate regulatory
protein network, and imbalances in this fragile homeo-
static regulation can easily lead to neurodegenerative
disorders [3]. Molecular genetic evidence on apolipopro-
tein E isoforms has implications for cholesterol in the
onset of Alzheimer’s disease (AD) [4]. Moreover, a
plethora of data suggest that statins, HMG CoA reductase
(HMGR) inhibitors widely used in therapies against
hypercholesterolemia, could reduce the risk of developing
AD [5]. Despite this evidence, no systematic research is
being done to study the putative deregulation of cho-
lesterol homeostasis in AD. Here, we analyzed the main
proteins involved in cholesterol homeostasis maintenance
in Tg2576 mouse model of AD.
Materials and methods
Activation state and protein expression of HMGR, LRP1,
LDLr and SRB1 were evaluated by Western blot both in
hippocampus and brain cortex of Tg2576 transgenic mice.
Neuronal and/or astrocytic protein localization was
analyzed by immunofluorescence double staining.
Results
No alterations were detectable in the activation state and
protein level expression of HMGR, the key enzyme com-
mitted to cholesterol biosynthesis. By contrast, the
expression of lipoprotein receptors LDLr, LRP1 and
SRB1 were strongly increased in the hippocampus of
Tg2576 if compared to age-matched wild type mice.
Conclusions
The present work shows profound and marked alterations
in the main proteins involved in lipoprotein metabolism,
suggesting that local cholesterol transport could be
impaired in a mouse model of AD. Whether these modi-
fications could be the cause or the consequence of the
disease still remains to be elucidated. A better comprehen-
sion of the molecular basis linking cholesterol metabolism
and AD could be of importance when designing novel
therapeutic strategies for neurodegenerative pathologies.
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